Immunisation Community of Practice

Share Immunisation Community of Practice on Facebook Share Immunisation Community of Practice on Twitter Share Immunisation Community of Practice on Linkedin Email Immunisation Community of Practice link

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.
  • Update on Shingrix supply

    Share Update on Shingrix supply on Facebook Share Update on Shingrix supply on Twitter Share Update on Shingrix supply on Linkedin Email Update on Shingrix supply link

    Please be advised that the NSW Immunisation Unit expects to receive additional supplies of Shingrix® vaccines from today and will be opening ordering as soon as they are able.

    The letter below will be sent out today to Immunisation Providers advising of same.

  • NSW Health Alert: Pertussis (Whooping cough) alert

    Share NSW Health Alert: Pertussis (Whooping cough) alert on Facebook Share NSW Health Alert: Pertussis (Whooping cough) alert on Twitter Share NSW Health Alert: Pertussis (Whooping cough) alert on Linkedin Email NSW Health Alert: Pertussis (Whooping cough) alert link

    Pertussis (Whooping Cough) - Information for GPs [27 March 2024]

    There has been a rise in Pertussis (‘whooping cough’) cases in NSW after circulating at very low levels during the pandemic.

    Pertussis is caused by Bordetella pertussis and spreads mainly through respiratory droplets.

    Pertussis outbreaks usually occur every few years as population immunity wanes. Notifications of people with pertussis in NSW are starting to increase from a very low level and are expected to increase further.

    Infants aged under 6 months are at greatest risk of severe disease, hospitalisation and death.

    Consider pertussis and order a PCR test for people with a compatible illness, even if fully vaccinated.

    Ensure that all patients are up to date with recommended vaccinations; this is especially important for:

    • pregnant women, who should be vaccinated between 20-32 weeks gestation (ideally at 28 weeks) to provide antibodies to their infant for protection in the first few months of life
    • infants and their siblings
    • adults who care for infants under 6 months who have not received a booster in the last 10 years.
    • Refer to the Australian Immunisation Handbook for details.


  • NEW! Authorised Registered Nurse/Midwife Vaccination Standards and Authority update to protect against RSV

    Share NEW! Authorised Registered Nurse/Midwife Vaccination Standards and Authority update to protect against RSV on Facebook Share NEW! Authorised Registered Nurse/Midwife Vaccination Standards and Authority update to protect against RSV on Twitter Share NEW! Authorised Registered Nurse/Midwife Vaccination Standards and Authority update to protect against RSV on Linkedin Email NEW! Authorised Registered Nurse/Midwife Vaccination Standards and Authority update to protect against RSV link

    The Authorised Nurse Immuniser and Authorised Midwife Immunisers Policy Directive (PD2024_004) has been rescinded and replaced with the newly developed NSW Authorised Registered Nurse/Midwife Vaccination Standards (the Standards). Authority and Standards for RNs and Midwifes

    Key updates

    • The mandatory conditions which Authorised Nurse/Midwife Immunisers (ANIs) must comply with to ensure effective and efficient immunisation service delivery are now outlined in the Standards. These conditions have not changed for ANIs working in NSW Health, the requirements in the Standards remain consistent with the previous policy.
    • The rescinding of PD2024_004 and the creation of the Standards mandate that all ANIs in NSW including those working in primary care or private practice, who initiate and administer a vaccine comply with both the Authority and the Standards.
    • The updated Authority and new Standards include products that protect against respiratory syncytial virus (RSV) including the new RSV vaccines and RSV monoclonal antibodies (mAbs), Beyfortus ™ (nirsevimab). ANIs must comply with the requirements in the Australian Technical Advisory Group on Immunisation (ATAG) recommendations when administering these immunisations. Information on the NSW RSV vulnerable babies program is available on the NSW Health webpage: https://www.health.nsw.gov.au/immunisation/Pages/respiratory-syncytial-virus.aspx
  • Happy Immunisation Week! 24th - 30th April

    Share Happy Immunisation Week! 24th - 30th April on Facebook Share Happy Immunisation Week! 24th - 30th April on Twitter Share Happy Immunisation Week! 24th - 30th April on Linkedin Email Happy Immunisation Week! 24th - 30th April link
    supporting image

    World Immunisation Week 2024: Humanly Possible: Immunization for All

    World Immunization Week 2024 (who.int)

  • 2024 Seasonal Influenza Vaccination Program

    Share 2024 Seasonal Influenza Vaccination Program on Facebook Share 2024 Seasonal Influenza Vaccination Program on Twitter Share 2024 Seasonal Influenza Vaccination Program on Linkedin Email 2024 Seasonal Influenza Vaccination Program link
    supporting image

    2024 seasonal influenza vaccination information for immunisation providers

  • Staying healthy these holidays

    Share Staying healthy these holidays on Facebook Share Staying healthy these holidays on Twitter Share Staying healthy these holidays on Linkedin Email Staying healthy these holidays link
    supporting image

    If you're planning a trip away this Easter or school holidays, protect yourself and others from illnesses like COVID-19 and influenza.

    Remember to practise protective behaviours such as:

    • getting vaccinated

    • washing your hands regularly

    • coughing or sneezing into your elbow or a tissue

    • staying home and rescheduling visits to family and friends when you're unwell.

    If you do get sick these holidays, you can book an appointment with a GP using the Healthdirect Service Finder.

    For more information on COVID-19 and influenza, visit the Department of Health and Aged Care website.

    Learn more about COVID-19 and Influenza

  • New South Wales announce RSV (respiratorysyncytialvirus) immunisation program

    Share New South Wales announce RSV (respiratorysyncytialvirus) immunisation program on Facebook Share New South Wales announce RSV (respiratorysyncytialvirus) immunisation program on Twitter Share New South Wales announce RSV (respiratorysyncytialvirus) immunisation program on Linkedin Email New South Wales announce RSV (respiratorysyncytialvirus) immunisation program link
    supporting image

    Beyfortus (nirsevimab) – NSW Health RSV (Respiratory Syncytial Virus) vulnerable babies program

    NSW Health RSV (respiratory syncytial virus) vulnerable babies program will be implemented in a phased approach that prioritises the most vulnerable babies and infants.

    Infants who are vulnerable to severe illness from RSV are eligible for a free monoclonal antibody Beyfortus (nirsevimab) immunisation. RSV monoclonal antibodies are a passive immunisation that provides antibodies directly to the infant so they have immediate protection against RSV. The trade name of nirsevimab is Beyfortus.

    Beyfortus (nirsevimab) will be initially offered to hospitalised infants in 2024 who meet the following eligibility criteria:

    • babies born before 37 weeks gestation and after 31 October 2023
    • Aboriginal and Torres Strait Islander babies born after 31 October 2023
    • other infants living with specific chronic and complex health conditions.

    https://www.health.nsw.gov.au/immunisation/Pages/respiratory-syncytial-virus.aspx


  • COVID-19: 2024 advice updated in the Australian Immunisation Handbook

    Share COVID-19: 2024 advice updated in the Australian Immunisation Handbook on Facebook Share COVID-19: 2024 advice updated in the Australian Immunisation Handbook on Twitter Share COVID-19: 2024 advice updated in the Australian Immunisation Handbook on Linkedin Email COVID-19: 2024 advice updated in the Australian Immunisation Handbook link

    The Australian Immunisation Handbook has been updated with information about COVID-19, vaccines and recommendations for vaccination.

    Link: COVID-19 | The Australian Immunisation Handbook (health.gov.au)

  • Influenza 2024 Resources

    Share Influenza 2024 Resources on Facebook Share Influenza 2024 Resources on Twitter Share Influenza 2024 Resources on Linkedin Email Influenza 2024 Resources link
    supporting image

    Influenza 2024 Resources

    Clinical resources

    • The Australian Immunisation Handbook The Australian Immunisation Handbook provides clinical guidelines for healthcare professionals about using vaccines safely and effectively.
    • NSW Immunisation schedule (NSW Health) Vaccines funded under the National Immunisation Program
    • Winter Planning Toolkit RACGP Winter Planning Toolkit which highlights key priorities and principals of infection prevention and control; workforce protection and planning; processes for patient management; and managing the risk of cross-infection.
    • Infection Prevention and Control Practice Handbook Clinical Excellence Commission handbook which includes practical day-to-day guidance to support the implementation of NSW Health Infection Prevention and Control Policy directive.


  • COVID-19 vaccine advice and recommendations for 2024

    Share COVID-19 vaccine advice and recommendations for 2024 on Facebook Share COVID-19 vaccine advice and recommendations for 2024 on Twitter Share COVID-19 vaccine advice and recommendations for 2024 on Linkedin Email COVID-19 vaccine advice and recommendations for 2024 link

    The Australian Technical Advisory Group on Immunisation (ATAGI) has recently published new advice for 2024 on COVID-19 vaccines https://www.health.gov.au/our-work/covid-19-vaccines/getting-your-vaccination/booster-doses

    In 2024, those aged 75 years and over continue to be recommended a dose of COVID-19 vaccine every six months.

    • Those aged over 65 years of age, and adults with severe immunocompromise, continue to be eligible to receive a COVID-19 vaccine dose every 6 months.

    • All other adults can receive a single dose this year.

    Clinical recommendations for COVID-19 vaccines can be found in the COVID-19 chapter of the Australian Immunisation Handbook (the Handbook). The Handbook is in the process of being updated to reflect updates in 2024, with updates available in the coming weeks.

    Recommended COVID-19 vaccine doses

    COVID-19 Vaccines in Australia – A3 poster


Page last updated: 07 Jun 2024, 02:19 PM